Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

208
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
208
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

272
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
272
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

426
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
426
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

456
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
456
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

485
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
485
Clearance Models: Noncompartmental Models01:17

Clearance Models: Noncompartmental Models

214
Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
214

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sparse Canonical Correlation Analysis for Multiple Measurements With Latent Trajectories.

Biometrical journal. Biometrische Zeitschrift·2025
Same author

Estimating overall survival of glioblastoma patients using clinical variables, tumor size, and location.

Neuro-oncology advances·2025
Same author

Identifying Predictors for Heart Failure Outcomes in Phospholamban p.(Arg14del)-Positive Individuals.

JACC. Heart failure·2025
Same author

Application of image guided analyses to monitor fecal microbial composition and diversity in a human cohort.

Scientific reports·2025
Same author

Aortic Function in a Longitudinal 4D Flow MRI Study in Marfan Syndrome Patients Receiving Resveratrol.

Journal of magnetic resonance imaging : JMRI·2025
Same author

Cohort Profile Update: The Healthy Life in an Urban Setting (HELIUS) Study.

International journal of epidemiology·2025
Same journal

OpenIMC: an open-source platform for analyzing single-cell and spatial proteomics by imaging mass cytometry.

BMC bioinformatics·2026
Same journal

NAP: an open source pipeline for cross-domain microbiome profiling using Nanopore sequencing-derived amplicon data.

BMC bioinformatics·2026
Same journal

SurvGME: an R package for survival analysis with graphical and measurement error models.

BMC bioinformatics·2026
Same journal

SimMapNet: a Bayesian framework for gene regulatory network inference using gene ontology similarities as external hint.

BMC bioinformatics·2026
Same journal

Dual channel drug-drug interactions extraction based on cross attention.

BMC bioinformatics·2026
Same journal

FeSseqdb: a curated sequence-level database and interpretable machine learning framework for identifying iron-sulfur proteins.

BMC bioinformatics·2026
See all related articles

Related Experiment Video

Updated: Dec 31, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.9K

Multiset sparse partial least squares path modeling for high dimensional omics data analysis.

Attila Csala1, Aeilko H Zwinderman2, Michel H Hof2

  • 1Department of Clinical Epidemiology, Biostatistics and Bioinformatics, University of Amsterdam, Amsterdam, 1105 AZ, The Netherlands. a@csala.me.

BMC Bioinformatics
|January 11, 2020
PubMed
Summary
This summary is machine-generated.

We developed multiset sparse Partial Least Squares path modeling (msPLS) to analyze multiple high-dimensional omics data. This method identifies biological pathways and biomarkers for complex diseases, offering interpretable results.

Keywords:
High dimensional omics dataMultivariate analysisPartial least squares

More Related Videos

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
05:01

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

Published on: July 1, 2020

3.6K
Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

3.1K

Related Experiment Videos

Last Updated: Dec 31, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.9K
A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
05:01

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

Published on: July 1, 2020

3.6K
Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

3.1K

Area of Science:

  • Computational biology
  • Statistical genetics
  • Bioinformatics

Background:

  • High-dimensional omics data analysis is challenging due to the complexity and volume of data.
  • Existing methods struggle to integrate multiple omics data sources and account for their hierarchical structure.
  • Interpreting genomewide results from multi-omics analyses remains a significant hurdle.

Purpose of the Study:

  • To propose a novel statistical method, multiset sparse Partial Least Squares path modeling (msPLS), for simultaneous analysis of multiple omics data.
  • To address the challenges of integrating hierarchical omics data and providing interpretable results.
  • To model biological pathways and genetic architectures of complex phenotypes using multi-omics data.

Main Methods:

  • Developed msPLS, a generalized penalized form of Partial Least Squares path modeling.
  • msPLS simultaneously models effects of molecular markers from multiple omics domains on phenotypic variables.
  • The method incorporates relationships between data sources and provides sparse, interpretable results.

Main Results:

  • Simulation studies validated msPLS's ability to discover associated variables in high-dimensional data.
  • Applied msPLS to omics datasets for Marfan syndrome and Chronic Lymphocytic Leukaemia, exploring associated biological pathways.
  • Compared msPLS with Multi-Omics Factor Analysis (MOFA), demonstrating superior performance in certain aspects.

Conclusions:

  • msPLS is an effective multivariate method for integrative analysis of multiple high-dimensional omics data.
  • The method provides interpretable biomarker identification through sparse solutions.
  • msPLS identified relevant biological pathways for Marfan syndrome and CLL, outperforming MOFA in explaining variation in CLL data.